1-2 of 2
Keywords: Bisphosphonate
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Loading-Dose Ibandronate Treatment in Patients with Breast Cancer and Bone Metastases Suffering from Moderate to Severe Pain

Subject Area:
Oncology
Kadri Altundag, Omer Dizdar, Zeynep Ozsaran, Serdar Ozkok, Pinar Saip, Yesim Eralp, Seref Komurcu, Okan Kuzhan, Mustafa Ozguroglu, Metin Karahoca
Journal: Onkologie
Onkologie (2012) 35 (5): 254–258.
https://doi.org/10.1159/000338369
Published Online: 24 April 2012
... to in the content or advertisements. Intravenous Bisphosphonate Bone pain Breast cancer Ibandronate Bone metastases Original Article · Originalarbeit Onkologie 2012;35:254 258 DOI: 10.1159/000338369 Published online: April 24, 2012 Phase II Study of Loading-Dose Ibandronate Treatment in Patients...
View article titled, Phase II Study of Loading-Dose Ibandronate Treatment in Patients with Breast Cancer and Bone Metastases Suffering from Moderate to Severe Pain
Open the PDF for Phase II Study of Loading-Dose Ibandronate Treatment in Patients with Breast Cancer and Bone Metastases Suffering from Moderate to Severe Pain in another window
Journal Articles

Results of the Zometa® Cost-Utility Model for the German Healthcare System Based on the Results of the ABCSG-12 Study

Subject Area:
Oncology
Michael P. Lux, Claudia Reichelt, Diethelm Wallwiener, Rolf Kreienberg, Walter Jonat, Michael Gnant, Matthias W. Beckmann, Falk C. Thiel
Journal: Onkologie
Onkologie (2010) 33 (7): 360–368.
https://doi.org/10.1159/000315699
Published Online: 22 June 2010
.... Zoledronic acid Breast cancer Bisphosphonate Cost-utility analysis Original Article · Originalarbeit Onkologie 2010;33:360 368 DOI: 10.1159/000315699 Published online: June 22, 2010 Results of the Zometa® Cost-Utility Model for the German Healthcare System Based on the Results of the ABCSG-12 Study...
View article titled, Results of the Zometa® Cost-Utility Model for the German Healthcare System Based on the Results of the ABCSG-12 Study
Open the PDF for Results of the Zometa® Cost-Utility Model for the German Healthcare System Based on the Results of the ABCSG-12 Study in another window